Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HRS 25: The BIO-LIBRA Study
Author(s): Valentina Kutyifa Added: 3 weeks ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more

Demographic

Electrophysiology & Arrhythmia
THT 2025: GSN Ablation in HFpEF
Author(s): Marat Fudim Added: 3 months ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat… View more

Heart Failure
HFA 24: MONITOR-HF Subgroup Analysis
Author(s): Jasper J Brugts Added: 1 year ago
HFA 24 - We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672).MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation,… View more

Heart Failure
Management of Venous Thromboembolism
Author(s): Nazli Okumus , Ashley Park , Eugene Yuridistky , et al Added: 5 months ago

Anticoagulation

Vascular Disease and Surgery
LINC 25: The PATCH Study
Author(s): Sean Lyden Added: 3 months ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more

Vascular Disease and Surgery

Intervention
Transseptal Access After Interatrial Shunt Devices: Try Everything Once and Great Things Twice
Author(s): Molly Silkowski , Nicholas Amoroso Added: 1 year ago

Heart Failure

Electrophysiology & Arrhythmia
AHA 24 Late-Breaking Discussion: The ZODIAC Trial
Author(s): Harriette Van Spall , Kausik Ray Added: 6 months ago
AHA Conference 2024 — Key findings from the ZODIAC trial investigating the role of a decision support system in optimising lipid-lowering therapy for ACS patients.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Kausik Ray (Imperial College London, UK) to discuss the findings from the randomized controlled ZODIAC trial assessing decision support systems (DSS) in optimising… View more

Prevention & Chronic Conditions

MI/ACS
Transcatheter LAA Closure
Author(s): Chirag Bavishi Added: 2 years ago

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
HFA 24: The RELIEVE-HF Trial: Differential Effects of V-Wave Device
Author(s): Michael R Zile Added: 1 year ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had… View more

Heart Failure
CardioNerds @AHA23: ARIES HM3: Avoidance of Aspirin with LVAD Devices
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 1 year ago
AHA 2023 - Investigator, Dr Mandeep Mehra (Brigham and Women's Hospital, US) is interviewed by Dr Christian Inchaustegui (Oregon Health & Science University, US), CardioNerds Ambassador, on the findings of the ARIES HM3 trial (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES… View more

Heart Failure

Electrophysiology & Arrhythmia